AK
Atul Kumar Shukla
About Atul Kumar Shukla
Data last updated:
Atul Kumar Shukla was a Director at Glydus Remedies Private Limited (2020–2023) and Director at Sternum Pharmaceuticals Private Limited (2019–2022). The companies operate in Healthcare and Chemicals.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glydus Remedies Private Limited U74999UP2017PTC097118 | Director | 19 Oct 2020 | 2017 | ₹1.16 Cr (FY 2025) | Active |
| Sternum Pharmaceuticals Private Limited U24100UP2019PTC119829 | Director | 05 Aug 2019 | 2019 | ₹12 Lakh (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Atul Kumar Shukla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Atul Kumar Shukla
Atul Kumar Shukla was first appointed on 05 Aug 2019 as Director at Sternum Pharmaceuticals Private Limited. The most recent appointment on record is 19 Oct 2020 at Glydus Remedies Private Limited.
Atul Kumar Shukla held 2 earlier board appointments: Glydus Remedies Private Limited (Director, 19 Oct 2020 to 20 Feb 2023); Sternum Pharmaceuticals Private Limited (Director, 05 Aug 2019 to 11 Nov 2022).